Cite

HARVARD Citation

    Eşkazan, A. et al. (2021). Tocilizumab in COVID-19: The Cerrahpaşa-PREDICT score. Journal of infection and chemotherapy. 27 (9), pp. 1329-1335. [Online]. 
  
Back to record